Əsas səhifə

Çap

Əks əlaqə

İnfo
Nutritional interventions for reducing morbidity and mortality in people with HIV

Mündəricat

Nutritional interventions for reducing morbidity and mortality in people with HIV

Sübutlu məlumatların xülasələri
09.07.2015 • Sonuncu dəyişiklik 09.07.2015
Editors

Macronutrient supplementation may not decrease morbidity and mortality in people living with HIV, although energy intake is improved.

A Cochrane review included 14 studies with 1725 HIV positive adults and 271 HIV positive children.

Neither supplementary food nor daily supplement of Spirulina significantly altered the risk of death compared with no supplement or placebo in malnourished, ART naive adult participants in the two studies which reported on this outcome. A nutritional supplement enhanced with protein did not significantly alter the risk of death compared to standard nutritional care in children with prolonged diarrhoea. Supplementation with macronutrient formulas given to provide protein and/or energy and fortified with micronutrients, in conjunction with nutrition counselling, significantly improved energy intake (3 trials; n=131; MD 393.57 kcal/day; 95% CI 224.66 to 562.47) and protein intake (2 trials; n=81; MD 23.5 g/day; 95% CI 12.68, 34.01) compared with no nutritional supplementation or nutrition counselling alone in adult participants with weight loss. In general supplementation with specific macronutrients such as amino acids, whey protein concentration or Spirulina did not significantly alter clinical, anthropometric or immunological outcomes compared with placebo in HIV-infected adults and children.

on the effectiveness of various macronutrient interventions in people living with HIV infection, with a total of 486 subjects. None of the studies reported on mortality, morbidity, or disease progression. Overall, macronutrient supplementation (with or without nutritional counselling) significantly improved energy intake (5 trials; n=254; WMD 367 kcal/day; 95% CI: 217 to 516) and protein intake (3 trials; n=128; WMD 17 g/day; 95% CI 8 to 26) compared with no nutritional supplementation or placebo. There was no evidence of an effect on body weight (8 trials; n=423; WMD 0.24 kg; 95% CI –0.6 to 1.1), fat mass (6 trials; n=305; WMD –0.73 kg; 95% CI: –1.83 to 0.37), fat-free mass (5 trials; n=311; WMD 0 kg; 95% CI: -2.3 to 2.4) or CD4 count (6 trials; n=271; WMD 0.23 cells/mm3; 95% CI –40.2 to 40.6).

Comment: The quality of evidence is downgraded (2 steps) by imprecise results (few patients and wide confidence intervals).

Ədəbiyyat

  1. Grobler L, Siegfried N, Visser ME et al. Nutritional interventions for reducing morbidity and mortality in people with HIV. Cochrane Database Syst Rev 2013;2():CD004536.